Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;23(7):1051-3.
doi: 10.1101/gr.157826.113.

Hypothesis-generating research and predictive medicine

Affiliations
Review

Hypothesis-generating research and predictive medicine

Leslie G Biesecker. Genome Res. 2013 Jul.

Abstract

Genomics has profoundly changed biology by scaling data acquisition, which has provided researchers with the opportunity to interrogate biology in novel and creative ways. No longer constrained by low-throughput assays, researchers have developed hypothesis-generating approaches to understand the molecular basis of nature-both normal and pathological. The paradigm of hypothesis-generating research does not replace or undermine hypothesis-testing modes of research; instead, it complements them and has facilitated discoveries that may not have been possible with hypothesis-testing research. The hypothesis-generating mode of research has been primarily practiced in basic science but has recently been extended to clinical-translational work as well. Just as in basic science, this approach to research can facilitate insights into human health and disease mechanisms and provide the crucially needed data set of the full spectrum of genotype-phenotype correlations. Finally, the paradigm of hypothesis-generating research is conceptually similar to the underpinning of predictive genomic medicine, which has the potential to shift medicine from a primarily population- or cohort-based activity to one that instead uses individual susceptibility, prognostic, and pharmacogenetic profiles to maximize the efficacy and minimize the iatrogenic effects of medical interventions.

PubMed Disclaimer

References

    1. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, et al. 2011. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3: 65ra64 - PMC - PubMed
    1. Biesecker LG 2013. Incidental findings are critical for genomics. Am J Hum Genet 92: 648–651 - PMC - PubMed
    1. Biesecker LG, Mullikin JC, Facio FM, Turner C, Cherukuri PF, Blakesley RW, Bouffard GG, Chines PS, Cruz P, Hansen NF, et al. 2009. The ClinSeq Project: Piloting large-scale genome sequencing for research in genomic medicine. Genome Res 19: 1665–1674 - PMC - PubMed
    1. Hennekam RC, Biesecker LG 2012. Next-generation sequencing demands next-generation phenotyping. Hum Mutat 33: 884–886 - PMC - PubMed
    1. International Human Genome Sequencing Consortium 2004. Finishing the euchromatic sequence of the human genome. Nature 431: 931–945 - PubMed

LinkOut - more resources